Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy

NCT00188149 is registered in ClinicalTrials.gov with University Hospital Carl Gustav Carus as lead sponsor.

NCT NCT00188149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00188149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy
Lead sponsor
University Hospital Carl Gustav Carus
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2000
Completion date
December 31, 2007
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease